Table 4. Routes of infection and delivered doses of Select Agents used to infect guinea pigs and rabbits for tissue collection in study of inactivation of bacterial Tier 1 Select Agents.
Bacteria | Route of infection | Delivered dose, CFU | Animal model | Time of collection | Tissue collected |
---|---|---|---|---|---|
Bacillus anthracis Ames (spores) | Intradermal | 2.7 × 108 | Guinea pigs-Hartley | 2 h after challenge | Skin |
Inhalational and/or intramuscular, respiratory | 4.9 × 106 and 1.0 × 103 respiratory | Guinea pigs-Strain 13 | Late-stage disease | Lung, liver, spleen | |
|
Inhalational |
1.0 × 107 |
Rabbits-New Zealand White |
24 h after challenge |
Lung |
Burkholderia pseudomallei 1026b |
Intraperitoneal |
9.0 × 102 |
Guinea pigs-Strain 13 |
Late-stage disease |
Lung, liver, spleen |
Francisella tularensis Schu S4 |
Subcutaneous |
8.6 × 102 |
Guinea pigs-Strain 13 |
Late-stage disease |
Lung, liver spleen |
Yersina pestis CO92 | Subcutaneous | 7.0 × 104 | Guinea pigs-Strain 13 | Late-stage disease | Lung, liver, spleen |